April 2011
Volume 52, Issue 14
ARVO Annual Meeting Abstract  |   April 2011
New Opa1 Mouse Model: From Dominant Optic Atrophy To DOA "Plus" Phenotype
Author Affiliations & Notes
  • Emmanuelle Sarzi
    Inserm U583, Institut des Neurosciences de Montpellier, Montpellier, France
  • Claire Prouteau
    Service de Biochimie, Inserm U694, Angers, France
  • Chantal Cazevieille
    Centre Régional d'Imagerie Cellulaire, Montpellier, France
  • Guy Bielicki
    Plateforme RMN des systèmes biologiques, INRA UR 370, Saint-Genès Champanelle, France
  • Nathalie Boddaert
    Service de Radiologie Pédiatrique, Hôpital Necker Enfants Malades, Paris, France
  • Valérie Rigau
    laboratoire d'Anatomie et Cytologie Pathologiques, Hôpital Guy de Chauliac, Montpellier, France
  • Cécile Delettre
    Inserm U583, Institut des Neurosciences de Montpellier, Montpellier, France
  • Christian Hamel
    Inserm U583, Institut des Neurosciences de Montpellier, Montpellier, France
  • Pascal Reynier
    Service de Biochimie, Inserm U694, Angers, France
  • Guy Lenaers
    Inserm U583, Institut des Neurosciences de Montpellier, Montpellier, France
  • Footnotes
    Commercial Relationships  Emmanuelle Sarzi, None; Claire Prouteau, None; Chantal Cazevieille, None; Guy Bielicki, None; Nathalie Boddaert, None; Valérie Rigau, None; Cécile Delettre, None; Christian Hamel, None; Pascal Reynier, None; Guy Lenaers, None
  • Footnotes
    Support  Inserm, AFM
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 5881. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Emmanuelle Sarzi, Claire Prouteau, Chantal Cazevieille, Guy Bielicki, Nathalie Boddaert, Valérie Rigau, Cécile Delettre, Christian Hamel, Pascal Reynier, Guy Lenaers; New Opa1 Mouse Model: From Dominant Optic Atrophy To DOA "Plus" Phenotype. Invest. Ophthalmol. Vis. Sci. 2011;52(14):5881.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : Dominant Optic Atrophy (DOA) is an inherited mitochondrial disease mainly caused by mutations in the OPA1 gene, encoding a mitochondrial dynamin involved in membrane dynamics and control of apoptosis. DOA is characterized by visual failure marked by a loss of Retinal Ganglion Cells. Recently, detailed characterization of DOA patients previously thought to be non-syndromic revealed neuromuscular involvements.

Methods: : We generated a new Opa1 mouse model carrying the c.2708delTTAG mutation (Opa1+/Δ58), the most frequent mutation found in patients with DOA. Firstly, using molecular, electrophysiological and immuno-histological approaches, we characterized the visual function of this mouse. Secondly, we assessed mitochondrial respiratory chain activities in several tissues. Finally, we studied neuromuscular functions using behavioural, histological and molecular experiments as well as MRI technology

Results: : From the age of 9 months, Opa1+/Δ58 mice present altered visual function. We demonstrated a loss of the retinal ganglion cells, hallmark of DOA and demyelination abnormalities in optic nerve. Interestingly, at 5 months before the appearance of the visual defect, we detected a mitochondrial respiratory chain deficiency (RC) in retina and skeletal muscle. Mitochondrial distribution and structure are also affected in both tissues. We observed myopathic COX negative and Ragged Red Fibres in Opa1+/Δ58 mice as well as significant muscular weakness but no mtDNA instability. MRI analysis revealed cerebral abnormalities in mutant mice

Conclusions: : Here we described a mouse model of DOA "plus" phenotype. We show that a mitochondrial RC primary defect precedes visual and neuromuscular failures. Our findings provide the evidence that mtDNA deletions are not responsible for the pathophysiology of DOA. For the first time in a DOA mouse model we show central and peripheral nervous system impairments. Opa1+/Δ58 mouse provides a good model of DOA and a noticeable tool to further understand syndromic mitochondrial pathologies

Keywords: neuro-ophthalmology: optic nerve • mitochondria • metabolism 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.